4AB.DE vs. 0R2V.L
Compare and contrast key facts about AbbVie Inc (4AB.DE) and Apple Inc. (0R2V.L).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: 4AB.DE or 0R2V.L.
Correlation
The correlation between 4AB.DE and 0R2V.L is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
4AB.DE vs. 0R2V.L - Performance Comparison
Key characteristics
4AB.DE:
0.45
0R2V.L:
0.25
4AB.DE:
0.73
0R2V.L:
0.69
4AB.DE:
1.11
0R2V.L:
1.10
4AB.DE:
0.49
0R2V.L:
0.37
4AB.DE:
1.44
0R2V.L:
1.14
4AB.DE:
8.64%
0R2V.L:
10.59%
4AB.DE:
29.01%
0R2V.L:
48.07%
4AB.DE:
-37.04%
0R2V.L:
-38.25%
4AB.DE:
-18.30%
0R2V.L:
-24.50%
Fundamentals
4AB.DE:
€2.08
0R2V.L:
$6.42
4AB.DE:
84.13
0R2V.L:
0.24
4AB.DE:
0.42
0R2V.L:
2.01
4AB.DE:
5.41
0R2V.L:
6.04
4AB.DE:
104.35
0R2V.L:
45.84
4AB.DE:
€44.02B
0R2V.L:
$400.37B
4AB.DE:
€31.21B
0R2V.L:
$186.70B
Returns By Period
In the year-to-date period, 4AB.DE achieves a -2.31% return, which is significantly higher than 0R2V.L's -19.59% return.
4AB.DE
-2.31%
-2.43%
-10.67%
13.01%
20.69%
15.34%
0R2V.L
-19.59%
7.16%
4.25%
12.03%
21.88%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
4AB.DE vs. 0R2V.L — Risk-Adjusted Performance Rank
4AB.DE
0R2V.L
4AB.DE vs. 0R2V.L - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc (4AB.DE) and Apple Inc. (0R2V.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
4AB.DE vs. 0R2V.L - Dividend Comparison
4AB.DE's dividend yield for the trailing twelve months is around 3.22%, more than 0R2V.L's 0.51% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
4AB.DE AbbVie Inc | 3.22% | 3.00% | 3.45% | 3.15% | 3.27% | 4.35% | 4.31% | 3.35% | 2.49% | 3.08% | 0.00% | 0.00% |
0R2V.L Apple Inc. | 0.51% | 0.40% | 0.49% | 0.71% | 0.49% | 0.59% | 1.05% | 1.79% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
4AB.DE vs. 0R2V.L - Drawdown Comparison
The maximum 4AB.DE drawdown since its inception was -37.04%, roughly equal to the maximum 0R2V.L drawdown of -38.25%. Use the drawdown chart below to compare losses from any high point for 4AB.DE and 0R2V.L. For additional features, visit the drawdowns tool.
Volatility
4AB.DE vs. 0R2V.L - Volatility Comparison
AbbVie Inc (4AB.DE) has a higher volatility of 14.26% compared to Apple Inc. (0R2V.L) at 11.64%. This indicates that 4AB.DE's price experiences larger fluctuations and is considered to be riskier than 0R2V.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
4AB.DE vs. 0R2V.L - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc and Apple Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
4AB.DE vs. 0R2V.L - Profitability Comparison
4AB.DE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc reported a gross profit of 10.71B and revenue of 15.10B. Therefore, the gross margin over that period was 70.9%.
0R2V.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Apple Inc. reported a gross profit of 44.87B and revenue of 95.36B. Therefore, the gross margin over that period was 47.1%.
4AB.DE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc reported an operating income of -1.49B and revenue of 15.10B, resulting in an operating margin of -9.9%.
0R2V.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Apple Inc. reported an operating income of 29.59B and revenue of 95.36B, resulting in an operating margin of 31.0%.
4AB.DE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc reported a net income of -22.00M and revenue of 15.10B, resulting in a net margin of -0.2%.
0R2V.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Apple Inc. reported a net income of 24.78B and revenue of 95.36B, resulting in a net margin of 26.0%.